Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Hanson

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Psychopharmacology|November 24, 1977
Anorexigenic and ancillary actions of MK-212 (6-chloro-2-(1-piperazinyl)-pyrazine; CPP)B V Clineschmidt, H M Hanson, A B Pflueger, et al.
Biochemical Pharmacology|May 1, 1970
Some biochemical and pharmacological actions of -methylphenylalanineM L Torchiana, C C Porter, C A Stone, et al.
Laboratory Animal Science|February 1, 1977
Effect of cage size on patterns of activity and health of beagle dogsM Hite, H M Hanson, N R Bohidar, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|October 1, 1976
Appetite stimulant activity of 3-carboxy-10,11-dihydrocyproheptadineB V Clineschmidt, H M Hanson, J C McGuffin, et al.
European Review of Aging and Physical Activity : Official Journal of the European Group for Research Into Elderly and Physical Activity|April 26, 2014
Accelerometry analysis of physical activity and sedentary behavior in older adults: a systematic review and data analysisE Gorman, H M Hanson, P H Yang, et al.
Biochemical Pharmacology|July 1, 1971
Some biochemical and pharmacological actions of (-) erythro-meta-(meta-chlorobenzyloxy)-2-(1-aminoethyl)-benzyl alcohol. A derivative of metaraminolM L Torchiana, C C Porter, C A Stone, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonistV J Lotti, R G Pendleton, R J Gould, et al.
Archives of Osteoporosis|August 29, 2020
Correction to: A 3i hip fracture liaison service with nurse and physician co-management is cost-effective when implemented as a standard clinical programL A Beaupre, D Lier, C Smith, et al.
Archives of Osteoporosis|July 24, 2020
A 3i hip fracture liaison service with nurse and physician co-management is cost-effective when implemented as a standard clinical programL A Beaupre, D Lier, C Smith, et al.
Archives of Osteoporosis|June 4, 2020
Implementation of an in-patient hip fracture liaison services to improve initiation of osteoporosis medication use within 1-year of hip fracture: a population-based time series analysis using the RE-AIM frameworkL A Beaupre, F Moradi, H Khong, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Psychopharmacology|November 24, 1977
Anorexigenic and ancillary actions of MK-212 (6-chloro-2-(1-piperazinyl)-pyrazine; CPP)B V Clineschmidt, H M Hanson, A B Pflueger, et al.
Biochemical Pharmacology|May 1, 1970
Some biochemical and pharmacological actions of -methylphenylalanineM L Torchiana, C C Porter, C A Stone, et al.
Laboratory Animal Science|February 1, 1977
Effect of cage size on patterns of activity and health of beagle dogsM Hite, H M Hanson, N R Bohidar, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|October 1, 1976
Appetite stimulant activity of 3-carboxy-10,11-dihydrocyproheptadineB V Clineschmidt, H M Hanson, J C McGuffin, et al.
European Review of Aging and Physical Activity : Official Journal of the European Group for Research Into Elderly and Physical Activity|April 26, 2014
Accelerometry analysis of physical activity and sedentary behavior in older adults: a systematic review and data analysisE Gorman, H M Hanson, P H Yang, et al.
Biochemical Pharmacology|July 1, 1971
Some biochemical and pharmacological actions of (-) erythro-meta-(meta-chlorobenzyloxy)-2-(1-aminoethyl)-benzyl alcohol. A derivative of metaraminolM L Torchiana, C C Porter, C A Stone, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonistV J Lotti, R G Pendleton, R J Gould, et al.
Archives of Osteoporosis|August 29, 2020
Correction to: A 3i hip fracture liaison service with nurse and physician co-management is cost-effective when implemented as a standard clinical programL A Beaupre, D Lier, C Smith, et al.
Archives of Osteoporosis|July 24, 2020
A 3i hip fracture liaison service with nurse and physician co-management is cost-effective when implemented as a standard clinical programL A Beaupre, D Lier, C Smith, et al.
Archives of Osteoporosis|June 4, 2020
Implementation of an in-patient hip fracture liaison services to improve initiation of osteoporosis medication use within 1-year of hip fracture: a population-based time series analysis using the RE-AIM frameworkL A Beaupre, F Moradi, H Khong, et al.
Pageof 2